Evolution of Direct Costs in the First Years of Rheumatoid Arthritis: Impact of Early versus Late Biologic Initiation - An Economic Analysis Based on the ESPOIR Cohort-Reference-Cited by-同舟云学术

Evolution of Direct Costs in the First Years of Rheumatoid Arthritis: Impact of Early versus Late Biologic Initiation - An Economic Analysis Based on the ESPOIR Cohort

Published:2014-05-08 Issue:5 Volume:9 Page:e97077
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Chevreul Karine,Haour Georges,Lucier Sandy,Harvard Stephanie,Laroche Marie-Laure,Mariette Xavier,Saraux Alain,Durand-Zaleski Isabelle,Guillemin Francis,Fautrel Bruno

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. Epidemiology of rheumatoid arthritis;Y Alamanos;Autoimmun Rev,2005

2. Is rheumatoid arthritis disappearing?;T Uhlig;Ann Rheum Dis,2005

3. Le Garrec M-A, Bouvet M, Koubi M (2012) Comptes nationaux de la santé –2011. DREES (Direction de la recherche, des études, de l’évaluation et des statistiques). Available: http://www.drees.sante.gouv.fr/IMG/pdf/comptes_sante_2011.pdf. Accessed June 1^st 2013.

4. Costs of rheumatoid arthritis in France: a multicenter study of 1109 patients managed by hospital-based rheumatologists;F Guillemin;J Rheumatol,2004

5. Disease status, costs and quality of life of patients with rheumatoid arthritis in France: the ECO-PR Study;G Kobelt;Joint Bone Spine,2008

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating Associations Between Access to Rheumatology Care, Treatment, Continuous Care, and Healthcare Utilization and Costs Among Older Individuals With Rheumatoid Arthritis;The Journal of Rheumatology;2023-01-15

2. Multidisciplinary team intervention to reduce the nocebo effect when switching from the originator infliximab to a biosimilar;RMD Open;2021-01

3. Direct Healthcare Costs Associated with Oligoarticular Juvenile Idiopathic Arthritis at a Single Center;International Journal of Rheumatology;2020-09-01

4. Economic burden of rheumatoid arthritis: a systematic review of literature in biologic era;Annals of the Rheumatic Diseases;2020-04-03

5. Economic Evaluation of Sequences of Biological Treatments for Patients With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response or Intolerance to Methotrexate in France;Value in Health;2020-04